Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin for prevention of tamoxifen-related endometrial and ovarian changes in women with breast cancer
IRCT20140820018866N9Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in breast cancer comparing Metformin with Placebo (2 arms). Primary endpoint: Ovarian cyst. Started Apr 2021; status: completed.
02
Drugs
metformin
03
Conditions
breast cancer
Beyond the preview
Go deeper on IRCT20140820018866N9.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20140820018866N9.